DataMEDS AI, Inc. MEDS
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -94.86% | -95.35% | -1,377.12% | -2,059.46% | -- |
| Total Depreciation and Amortization | -14.36% | 44.20% | 188.09% | 553.77% | -- |
| Total Amortization of Deferred Charges | 33,507.49% | 6,673.30% | -- | -- | -- |
| Total Other Non-Cash Items | 77.70% | 79.28% | 6,600.00% | 214,154.31% | -- |
| Change in Net Operating Assets | 0.99% | 30.75% | 153.83% | 144.02% | -- |
| Cash from Operations | -174.03% | -396.26% | -786.12% | -867.11% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 1,557.73% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.72% | -10.62% | -90.68% | -210.87% | -- |
| Cash from Investing | -1,230.60% | -514.84% | -292.85% | 151.09% | -- |
| Total Debt Issued | -5.37% | 899.87% | 1,066.20% | 6,667.97% | -- |
| Total Debt Repaid | 40.42% | -5,387.92% | -19,238.22% | -8,006.70% | -- |
| Issuance of Common Stock | 99.31% | 141.77% | 136,608.00% | 113,628.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29.86% | 144.74% | -399.38% | -- | -- |
| Cash from Financing | 215.97% | 143.31% | 502.99% | 13,553.07% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 476.88% | -210.83% | -195.99% | 405.44% | -- |